Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Cidara Therapeutics Inc (NASDAQ: CDTX)

 
CDTX Technical Analysis
3
As on 9th Jun 2023 CDTX STOCK Price closed @ 1.21 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.72 & Buy for SHORT-TERM with Stoploss of 0.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

CDTXSTOCK Price

Open 1.25 Change Price %
High 1.26 1 Day -0.03 -2.42
Low 1.20 1 Week -0.12 -9.02
Close 1.21 1 Month 0.17 16.35
Volume 586000 1 Year -0.24 -16.55
52 Week High 1.98 | 52 Week Low 0.43
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
CDTX
Daily Charts		 CDTX
Intraday Charts		 Whats New @
Bazaartrend		 CDTX
Free Analysis
 
CDTX Important Levels Intraday
RESISTANCE1.33
RESISTANCE1.29
RESISTANCE1.27
RESISTANCE1.24
SUPPORT1.18
SUPPORT1.15
SUPPORT1.13
SUPPORT1.09
 
CDTX Forecast April 2024
Share
4th UP Forecast1.98
3rd UP Forecast1.73
2nd UP Forecast1.58
1st UP Forecast1.43
1st DOWN Forecast0.99
2nd DOWN Forecast0.84
3rd DOWN Forecast0.69
4th DOWN Forecast0.44
 
CDTX Weekly Forecast
4th UP Forecast1.67
3rd UP Forecast1.52
2nd UP Forecast1.43
1st UP Forecast1.34
1st DOWN Forecast1.08
2nd DOWN Forecast0.99
3rd DOWN Forecast0.90
4th DOWN Forecast0.75
 
CDTX Forecast2024
4th UP Forecast4.49
3rd UP Forecast3.44
2nd UP Forecast2.79
1st UP Forecast2.14
1st DOWN Forecast0.28
2nd DOWN Forecast-0.37
3rd DOWN Forecast-1.02
4th DOWN Forecast-2.07
 
 
CDTX Other Details
Segment EQ
Market Capital 103184736.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
CDTX Address
CDTX
 
CDTX Latest News
 
Your Comments and Response on Cidara Therapeutics Inc
 
CDTX Business Profile
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel long-acting anti-infectives for the treatment and prevention of diseases in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop antiviral conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Address: 6310 Nancy Ridge Drive, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service